Clinical Outcomes and Cost-Effectiveness for the Implementation of a Wireless Vital Sign Monitor in Newborns: A Stepped-Wedge Cluster Randomized Trial

Assumpta Nantume of Neopenda in Uganda examines the clinical impact and cost-effectiveness of a wearable vital signs monitoring system, neoGuard, for critically ill newborns in Kenya where the newborn mortality rate is one of the highest in the world.

Grant ID
GCA/MNCH/round8/085
Implementing Organization
Neopenda
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Bill & Melinda Gates Foundation
Challenge
Top Priorities for Maternal, Neonatal, and Child Health in Africa
Initiatives
Grand Challenges Africa
Principal Investigator
Assumpta Nantume
Award Manager
Grand Challenges Africa
Individual Funder Information
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Product/Service Development
Project Primary Sector
Maternal, Newborn, and Adolescent Health
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
True